HLA-DRB1 Antikörper (AA 1-266)
HLA-DRB1
Reaktivität: Human
WB
Wirt: Kaninchen
Polyclonal
unconjugated
-
-
Target
Alle HLA-DRB1 Antikörper anzeigen
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Bindungsspezifität
-
AA 1-266
-
Reaktivität
-
Human
-
Wirt
-
Kaninchen
-
Klonalität
-
Polyklonal
-
Konjugat
-
Dieser HLA-DRB1 Antikörper ist unkonjugiert
-
Applikation
-
Western Blotting (WB)
-
Verwendungszweck
-
Rabbit polyclonal antibody raised against a full-length human HLA-DRB1 protein.
-
Sequenz
-
MVCLRLPGGS CMAVLTVTLM VLSSPLALAG DTRPRFLEYS TSECHFFNGT ERVRFLDRYF YNQEEYVRFD SDVGEYRAVT ELGRPSAEYW NSQKDILEDK RAAVDTYCRH NYGVGESFTV QRRVHPKVTV YPSKTQPLQH HNLLVCSVSG FYPGSIEVRW FRNGQEEKTG VVSTGLIHNG DWTFQTLVML ETVPRSGEVY TCQVEHPSVT SPLTVEWRAR SESAQSKMLS GVGGFVLGLL FLGAGLFIYF RNQKGHSGLQ PRGFLS
-
Kreuzreaktivität
-
Human
-
Produktmerkmale
-
Antibody reactive against mammalian transfected lysate.
-
Immunogen
-
HLA-DRB1 (AAH08403.1, 1 a.a. ~ 266 a.a) full-length human protein.
-
Top Product
-
Discover our top product HLA-DRB1 Primärantikörper
-
-
-
Applikationshinweise
-
Optimal working dilution should be determined by the investigator.
-
Beschränkungen
-
Nur für Forschungszwecke einsetzbar
-
-
Buffer
-
In 1x PBS, pH 7.4
-
Handhabung
-
Aliquot to avoid repeated freezing and thawing.
-
Lagerung
-
-20 °C
-
Informationen zur Lagerung
-
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
Target
-
HLA-DRB1
(Major Histocompatibility Complex, Class II, DR beta 1 (HLA-DRB1))
-
Andere Bezeichnung
-
HLA-DRB1 (HLA-DRB1 Produkte)
-
Synonyme
-
MGC108235 antikoerper, DRB1 antikoerper, DRw10 antikoerper, HLA-DR1B antikoerper, HLA-DRB antikoerper, SS1 antikoerper, major histocompatibility complex, class II, DR beta 1 antikoerper, hla-drb1 antikoerper, HLA-DRB1 antikoerper
-
Hintergrund
-
Full Gene Name: major histocompatibility complex, class II, DR beta 1
Synonyms: DRB1,FLJ76359,HLA-DR1B,HLA-DRB,HLA-DRB1*,SS1
-
Gen-ID
-
3123
-
Pathways
-
T-Zell Rezeptor Signalweg, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, CXCR4-mediated Signaling Events, Cancer Immune Checkpoints
-